Troponin-I enhances and is required for oncogenic overgrowth

Autor: Sergio Casas-Tintó, Manuel Serrano, Antonio Maraver, Alberto Ferrús
Přispěvatelé: Herrada, Anthony, Instituto Cajal, Consejo Superior de Investigaciones Científicas [Madrid] (CSIC), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Spanish National Cancer Research Center (CNIO)
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Male
MESH: Tumor Burden
Lung Neoplasms
Drosophila Cancer Cell competition Cell proliferation
Cell
Gene Expression
Animals
Genetically Modified

Drosophila Proteins
MESH: Animals
cell competition
musculoskeletal system
MESH: RNAi Therapeutics
Tumor Burden
medicine.anatomical_structure
Drosophila melanogaster
Oncology
cardiovascular system
[SDV.BBM.GTP] Life Sciences [q-bio]/Biochemistry
Molecular Biology/Genomics [q-bio.GN]

Rap1
Female
RNA Interference
Drosophila
MESH: Troponin I
MESH: Xenograft Model Antitumor Assays
MESH: Gene Expression
MESH: Drosophila Proteins
MESH: RNA Interference
Mice
Nude

[SDV.CAN]Life Sciences [q-bio]/Cancer
Biology
MESH: Drosophila melanogaster
MESH: Animals
Genetically Modified

03 medical and health sciences
Downregulation and upregulation
[SDV.CAN] Life Sciences [q-bio]/Cancer
[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry
Molecular Biology/Genomics [q-bio.GN]

Carcinoma
medicine
MESH: Mice
Nude

Animals
Humans
cancer
Gene
MESH: Humans
Cell growth
Troponin I
Cancer
medicine.disease
Xenograft Model Antitumor Assays
MESH: Male
MESH: Lung Neoplasms
030104 developmental biology
RNAi Therapeutics
cell proliferation
Cell culture
A549 Cells
Immunology
Cancer research
MESH: A549 Cells
MESH: Female
Priority Research Paper
Zdroj: Oncotarget
Oncotarget, Impact journals, 2016, 7 (33), pp.52631-52642. ⟨10.18632/oncotarget.10616⟩
Digital.CSIC. Repositorio Institucional del CSIC
instname
ISSN: 1949-2553
Popis: Human tumors of various tissue origins show an intriguing over-expression of genes not considered oncogenes, such as that encoding Troponin-I (TnI), a wellknown muscle protein. Out of the three TnI genes known in humans, the slow form, TNNI1, is affected the most. Drosophila has only one TnI gene, wupA. Here, we studied excess- and loss-of function of wupA in Drosophila, and assayed TNNI1 down regulation in human tumors growing in mice. Drosophila TnI excess-of-function increases proliferation and potentiates oncogenic mutations in Ras, Notch and Lgl genes. By contrast, TnI loss-of-function reduces proliferation and antagonizes the overgrowth due to these oncogenic mutations. Troponin-I defective cells undergo Flower- and Sparc-dependent cell competition. TnI can localize to the nucleus and its excess elicits transcriptional up-regulation of InR, Rap1 and Dilp8, which is consistent with the increased cell proliferation. Human tumor cell lines treated with a human Troponin-I peptide arrest in G/G. In addition, proliferation of non-smallcell lung carcinoma xenografts in mice is restrained by TNNI1 down-regulation. Thus, Troponin-I reveals a novel function in cell proliferation that may be of therapeutic interest in certain types of cancer.
Databáze: OpenAIRE